Trends - BioNtech vaccine - Business Recorder

World

Pfizer-BioNTech seek US approval of second Covid booster for 65+

WASHINGTON: Pfizer and BioNTech announced Tuesday they had formally asked the United States drug regulator for...

Published 16 Mar, 2022 11:22am

Business & Finance

BioNTech eyes up to 17bn euros in vaccine revenue in 2022

FRANKFURT: BioNTech said it would likely generate up to 17 billion euros ($19 billion) in 2022 revenue from the...

Published 11 Jan, 2022 08:38pm

World

Mexico City starts Covid vaccinations of minors at risk

MEXICO CITY: Mexico on Monday began Covid-19 vaccinations for adolescents with chronic diseases in the capital, the...

Published 26 Oct, 2021 10:00am

World

White House lays out plan to vaccinate kids ages 5 to 11

WASHINGTON: The Biden administration on Wednesday outlined its plan to vaccinate millions of kids ages 5 to 11 as...

Published 20 Oct, 2021 06:17pm

World

J&J files for authorization of COVID-19 vaccine booster

Pfizer has also asked the FDA to expand its vaccine approval to include boosters for all people aged 16 and older

Published 05 Oct, 2021 06:12pm

World

Bahrain approves third booster shot of Sputnik V

DUBAI: Bahraini authorities have authorised the use of a booster dose of the Sputnik V COVID-19 vaccine, the first...

Published 05 Sep, 2021 04:26am

World

US FDA grants full approval to Pfizer-BioNTech COVID-19 vaccine

While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated

Updated 23 Aug, 2021 07:20pm

Business & Finance

BioNTech says has supplied more than 1 billion COVID-19 vaccine doses so far

Pfizer late last month raised its forecast for its share of 2021 vaccine sales to $33.5 billion
That includes sales, milestone payments from partners and a share of gross profit in its partners' territories, the company added

Updated 09 Aug, 2021 05:14pm

Business & Finance

Pfizer raises 2021 COVID-19 vaccine sales forecast to $33.5 billion

New early data showed that a third dose generated virus-neutralizing antibodies more than 5 times higher in younger people and more than 11 times higher in older people than from two doses

Published 28 Jul, 2021 07:29pm

Print

US Covid cases hit new plateau as Delta variant rises

WASHINGTON: After declining fast for two months, the rate of Covid infections in the United States has levelled off...

Published 29 Jun, 2021 03:24am

World

US triples vaccines for Taiwan with 2.5 million-dose shipment

We are not allocating these doses, or delivering these doses, based on political or economic conditions. We are donating these vaccines with the singular objective of saving lives.

Published 19 Jun, 2021 07:39pm

Print

Pfizer shot gets US drug regulator nod for 12-15 year olds as India outbreak rages

WASHINGTON: The United States drug regulator authorized the Pfizer-BioNTech vaccine for children aged 12-15 as the...

Updated 12 May, 2021 10:26am

World

Pfizer/BioNTech jab confirmed to protect 95% in largest study yet

Before Thursday, the largest real-world study of the Pfizer/BioNTec vaccine, also in Israel, was nearly five times smaller, involving 1.2 million people.

Published 06 May, 2021 10:54am

Business & Finance

BioNTech nearing request for approval of longer-lasting version of COVID vaccine

"Our first formulation had to be stored and shipped at minus 80 degrees. We have now, in the meantime, a formulation which is not yet approved... which can be stored at two to eight degrees," Sahin told a Financial Times conference panel, adding that data packages were being prepared for regulators.

Published 04 May, 2021 05:41pm

World

Erdogan says Turkey expects more COVID-19 vaccine supplies soon

Turkey has so far been using vaccines developed by China's Sinovac Biotech Ltd and by Pfizer and BioNTech .
It has carried out nearly 23 million inoculations, with 13.7 million people, or 16% of the population, having received at least one dose.

Published 30 Apr, 2021 06:05pm

Business & Finance

Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU

The companies filed a similar request in the United States earlier this month for the vaccine, which is already authorized for use in people from 16 years of age in both the United States and the European Union.
The submissions are based on positive data from a late-stage clinical trial that enrolled 2,260 participants aged 12 to 15, the companies said.

Published 30 Apr, 2021 04:51pm

World

EU seals deal with Pfizer-BioNTech for up to 1.8bn doses of vaccine

This is the third contract sealed by the bloc with the two companies, which have already agreed to deliver 600 million doses under two previous contracts.

Published 23 Apr, 2021 04:28pm

Business & Finance

EU preparing orders for 1.8bn vaccine booster shots

The planned orders will be for so-called mRNA vaccines, with a preference for manufacturers who are EU-based or who have production facilities in Europe.
Only the Biontech/Pfizer vaccine, which is manufactured in Belgium and Germany, and Moderna, which manufactures in Spain and Switzerland, currently meet these requirements.

Published 09 Apr, 2021 06:54pm

World

BioNTech-Pfizer COVID-19 vaccine 100% effective on 12-15 year olds: study

The vaccine was 100% effective in protecting against symptomatic disease, said the companies, who tested the drug on more than 2,260 children during phase three trial.
Researchers also didn’t find any safety concerns, Pfizer and BioNTech said.

Updated 31 Mar, 2021 05:18pm

World

Europe to get 4mn more Pfizer/BioNTech COVID-19 shots this month

The doses to vaccinate two million people will be supplied in addition to the planned deliveries, to ease border movement and to tackle virus hotspots, the Commission said.
"To tackle aggressive variants of the virus and to improve the situation in hotspots, quick and decisive action is necessary," the president of the Commission, Ursula von der Leyen, said.

Updated 10 Mar, 2021 07:24pm

World

World Bank threatens to stop funding Lebanon's COVID-19 vaccines after reported violations

In its first operation funding the purchase of COVID-19 vaccines, the World Bank reallocated $34 million to help Lebanon start vaccinations.
"Upon confirmation of violation, World Bank may suspend financing for vaccines and support for COVID19 response across Lebanon!!"

Published 23 Feb, 2021 05:40pm

Business & Finance

Pfizer's COVID-19 vaccine supply to the EU 30pc below plans

EU still short of about 10 mln Pfizer vaccines – sources.
Shortfall concerns deliveries due to the bloc in December.
EU has allowed the export of millions of Pfizer doses.

Published 17 Feb, 2021 06:42pm

World

What you need to know about the coronavirus right now

The airline said pilots and cabin crew on three international flights from Singapore to Jakarta, Bangkok and Phnom Penh had received both of the required doses of the Pfizer-BioNTech vaccine.

Published 11 Feb, 2021 12:35pm

World

Britain has given 10 million people a first COVID-19 vaccine dose

"This is a hugely significant milestone in our national effort against this virus."
The country approved vaccines developed by Pfizer-BioNTech and Oxford University-AstraZeneca earlier than the United States and Europe, enabling it to make an early start on roll-out.

Published 03 Feb, 2021 09:15pm

Business & Finance

BioNTech 'confident' it will meet Japan's COVID-19 vaccine demand

Japan's vaccine chief said last week that export controls imposed by the European Union, where some vaccines are made, could delay the Asian nation's inoculation effort.
Pfizer and BioNTech have increased manufacturing capacity to more than 2 billion doses a year from 1.3 billion to meet demand.

Published 02 Feb, 2021 06:47pm

Business & Finance

BioNTech says working to supply vaccines to Japan as soon it can

BioNTech's vaccine supply to Japan will come from multiple sites, Richardson told an online media conference.

Published 02 Feb, 2021 05:37pm

Business & Finance

EU repeats Pfizer/BioNTech to deliver 75mn extra vaccine doses in Q2

BioNTech/Pfizer will deliver 75 million of additional doses in the second quarter of the year - and up to 600 millions in total in 2021.
BioNTech and Pfizer this month raised their supply goal for this year to 2 billion doses, up from a previous aim of 1.3 billion.

Published 01 Feb, 2021 06:36pm

Business & Finance

Swiss drugmaker Novartis to help make Pfizer-Biontech COVID-19 vaccine

Three vaccines from Western companies Pfizer-Biontech, AstraZeneca and Moderna have been approved by regulators.
Novartis has been mobilizing on multiple fronts to support the global pandemic response.

Published 29 Jan, 2021 05:15pm

Business & Finance

EU set to require authorisation for vaccine exports

The Commission, which has coordinated the orders, said on Tuesday it would propose that pharmaceutical firms be required to register their vaccine exports.
The decision will be taken tomorrow to start implementing this mechanism.

Published 28 Jan, 2021 09:17pm

Business & Finance

Italy to invest 81mn euros in biotech ReiThera for COVID vaccine development

Most of the money, some 69,3 million euros, will go directly on research and development while around 12 million will be used to expand the ReiThera vaccine production site, close to Rome.
The company aims to produce some 100 million shots of its vaccine per year.

Published 26 Jan, 2021 06:10pm